HERC2 and Hepatic failure: We postulated that LNP‐HERC2 preferentially accumulates in the vicinity of the central vein or portal vein areas, thereby reinforcing APAP resistance of hepatocytes and consequently conferring protection against APAP‐induced hepatic failure.